Biocompatible glyconanomaterials based on HPMA-copolymer for specific targeting of galectin-3
BACKGROUND: Galectin-3 (Gal-3) is a promising target in cancer therapy with a high therapeutic potential due to its abundant localization within the tumor tissue and its involvement in tumor development and proliferation. Potential clinical application of Gal-3-targeted inhibitors is often complicat...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6146777/ https://www.ncbi.nlm.nih.gov/pubmed/30236114 http://dx.doi.org/10.1186/s12951-018-0399-1 |